MOLECULAR INSIGHT PHARMACEUTICALS, INC.

 MOLECULAR INSIGHT PHARMACEUTICALS, INC. contact information is shown below
Owner:MOLECULAR INSIGHT PHARMACEUTICALS, INC.
Owner Address:160 Second Street Cambridge MA 02142
Owner Web Site
Owner Phone
Owner Toll Free
Owner Fax

 

Brands Owned byMOLECULAR INSIGHT PHARMACEUTICALS, INC.

Brand:

AZEDRA

Description:

Radiopharmaceutical compositions for treating neuro-endocrine cancers;

Category: RADIOPHARMACEUTICAL COMPOSITIONS TREATING NEURO ENDOCRINE
Brand:

AZEDRA

Description:

Pharmaceutical compositions for diagnosing and treating cancers;

Category: PHARMACEUTICAL COMPOSITIONS DIAGNOSING
Brand:

MOLECULAR INSIGHT

Description:

Instruments for the detection, screening, or diagnosis of cancer; instruments for the analysis of the molecular properties of biological samples; and instruments for spectroscopically determining properties of biological samples;

Category: INSTRUMENTS DETECTION
Brand:

MOLECULAR INSIGHT

Description:

Radiological, radiopharmaceutical and medicinal agents and preparations for the detection, screening, diagnosis and/or treatment of cancer, cardiac disease and neurological disorders;Color is not claimed as a feature of the mark.;MOLECULAR;

Category: RADIOLOGICAL
Brand:

MOLECULAR INSIGHT PHARMACEUTICALS - PIONEERS IN MEDICINE, PARTNERS IN CARE

Description:

Newsletters, bulletins concerning pharmaceutical development, pharmaceutical industry developments and issues and pharmaceutical investment;PHARMACEUTICALS AND PIONEERS IN MEDICINE, PARTNERS IN CARE;

Category: NEWSLETTERS
Brand:

MOLECULARINSIGHT PHARMACEUTICALS

Description:

The mark consists of the word molecularinsight in lowercase letters centered over the word pharmaceuticals, which is also in lowercase letters. Three stylized disks of increasing size appear to the right of the lettering.;MOLECULAR INSIGHT PHARMACEUTICALS;Color is not claimed as a feature of the mark.;Preparation of pharmaceutical drugs and imaging agents for medical use;PHARMACEUTICALS;Services for research and development of pharmaceutical drugs and imaging agents for medical use;

Category: